Cargando…

Environmental Sars-Cov-2 Surface Testing: Low Incidence of Virus Positivity in Outpatient and Inpatient Hematology/Oncology Settings

Introduction: Current evidence suggests that the COVID-19 related mortality and morbidity is higher in cancer patients due to increased visits to healthcare facilities (e.g., doctor's visits, phlebotomy, imaging, social work, financial consultations, therapy administration, etc) and inherent or...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shah, Mansi R, Jan, Imraan, Johns, Jeremy, Singh, Kuldip, Kumar, Pallavi, Belarmino, Norma, Saggiomo, Kara, Hayes, Carolyn, Toppmeyer, Deborah, Washington, Kimyatta, Haffty, Bruce, Libutti, Steven, Evens, Andrew M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Hematology 2020
Materias:	901.Health Services Research-Non-Malignant Conditions
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330342/ http://dx.doi.org/10.1182/blood-2020-136396

Ejemplares similares

Outcomes of COVID-19 Infection in Patients with Hematologic Malignancies
por: Behrens, Elizabeth, et al.
Publicado: (2020)

An Online Case-Based Clinical Elective in Hematology for Medical Students
por: Means, Robert T.
Publicado: (2020)

COVID-19 in Patients with Hematologic Malignancies: A Single-Center Experience
por: Wilde, Lindsay, et al.
Publicado: (2020)

Success and Satisfaction with Virtual Hematology Curriculum Implemented in Response to COVID-19
por: Gunesch, Ali Noel, et al.
Publicado: (2021)

The Impact of COVID-19 on Hematology-Oncology Fellowship Programs: Program Director Perspectives
por: Velazquez Manana, Ana I., et al.
Publicado: (2020)

Measuring the Impact of COVID-19 on Hematology-Oncology Trainees: A Quantitative and Qualitative Assessment
por: Durani, Urshila, et al.
Publicado: (2020)

COVID-19 Prognostic Score Utilizing Hematological and Inflammatory Markers to Determine Outcomes of Hospitalized Patients
por: Kalsi, Amardeep, et al.
Publicado: (2020)

Estimating Mortality in Patients with Hematological Malignancy and COVID-19: A Pooled Analysis of 10 Studies
por: Saini, Kamal S., et al.
Publicado: (2020)

Digital Platform for Evidence-Based Medicine in Hematology (non-malignant and malignant conditions) in a Developing Country
por: Rocha, Juliana, et al.
Publicado: (2020)

Impact on Mental Health, Disease Management and Socioeconomic Modifications in Hematological Patients during COVID-19 Pandemia in Italy
por: De Muro, Marianna, et al.
Publicado: (2020)

Perception and Psychological Help Seeking Behaviour Among Hematology Healthcare Workers during the COVID19 Pandemic in India
por: Prabha, Lakshmi, et al.
Publicado: (2020)

Social Media Validation for Pre-Screened Ontologies As a Driver for Biomolecular Interaction Significance in COVID-19 and Hematological Malignancies
por: Leyfman, Yan, et al.
Publicado: (2021)

Mental Health Assessment of Youth with Sickle Cell Disease and Their Primary Caretakers: Baseline Depression and COVID-19 Pandemic-Associated Psychosocial Stress in a Multi-Site Study
por: Green, Nancy S., et al.
Publicado: (2020)

Utilization of Telemedicine for Comprehensive Visits in Patients with Inherited Bleeding Disorders during the COVID-19 Pandemic
por: Wang, Cassandra P, et al.
Publicado: (2020)

COVID-19 Pandemic Highlights Health Disparities in Latinos in San Diego
por: Quiroz, Elisa, et al.
Publicado: (2020)

Influenza Vaccination in Asplenia: Improving Quality of Care in Time of Coronavirus
por: Di Maio, Nicoletta, et al.
Publicado: (2020)

COVID-19 Outcomes in Individuals with Sickle Cell Disease and Sickle Cell Trait Compared to Blacks without Sickle Cell Disease or Trait
por: Singh, Ashima, et al.
Publicado: (2020)

Impact of the COVID19 Pandemic on Admissions and Emergency Department Visits of Adults with Sickle Cell Disease
por: Cohen, Alice J.
Publicado: (2020)

Impact of a National Lockdown for COVID-19 on Morbidity and Mortality Among Children with Sickle Cell Anaemia at a Tertiary Care Hospital in Uganda
por: Namazzi, Ruth, et al.
Publicado: (2020)

Association of Anticoagulant Use with COVID-19 Diagnosis
por: Kavecansky, Juraj, et al.
Publicado: (2020)

COVID Symptoms and COVID Anxiety in Sickle Cell Disease
por: Smith, Wally R, et al.
Publicado: (2020)

Prospective Multicentric Observational Study of COVID19 in Oncohematological Patients in the Catalonia Region: The Opposite Effect of Steroids on Survival
por: Mussetti, Alberto, et al.
Publicado: (2020)

Critical Telehealth and Healthcare Utilization during COVID-19 in Sickle Cell Disease: CBO Reach in Understanding the Patient Experience
por: Fields, Jennifer, et al.
Publicado: (2020)

Clinical Impact of COVID-19 on Anticoagulation Management at the William S. Middleton Memorial Veterans Hospital
por: Hecht, Hannah, et al.
Publicado: (2020)

Impact of COVID19 Pandemic on an International MPN Patient Population: Survey Results from 1560 MPN Patients
por: Palmer, Jeanne M., et al.
Publicado: (2020)

Incidence of Venous Thromboembolic Events in Hospitalized COVID-19 Patients: A Systematic Review
por: Galllastegui Crestani, Nicolas, et al.
Publicado: (2020)

Covid-19 Disease Is Not Associated with Venous Thromboembolism in a Cohort of Patients in Jeddah, Saudi Arabia
por: Kamel, Fatemah, et al.
Publicado: (2020)

Impact of COVID 19 Pandemic on Health Care Utilization for Patients with Sickle Cell Disease - a Specialty Treatment Center Experience
por: Jain, Akshat, et al.
Publicado: (2021)

For Better or for Worse: COVID-19 Vaccination during or Early after (Immuno-) Chemotherapy or Hematopoietic Progenitor Cell Transplantation
por: Haggenburg, Sabine, et al.
Publicado: (2021)

Effects of the COVID-19 Pandemic on Caregivers of Young Children with Sickle Cell Disease Enrolled in the Engage-HU Trial
por: Hood, Anna M, et al.
Publicado: (2021)

Drepadom - Establishment of Home Care Services and Hospitalizations for Sickle Cell Disease Patients As Standard Care Since the Covid-19 Pandemic
por: Pelinski, Yanís, et al.
Publicado: (2021)

The Telemedicine Experience for Individuals with Sickle Cell Disease
por: Weiss, Sara, et al.
Publicado: (2021)

Complete Blood Count Parameters Outperform Putative Inflammatory Markers in Predicting COVID-19 Mortality: A Multimodal Machine Learning Model
por: Idogun, Precious, et al.
Publicado: (2021)

Outcomes of Patients with Hematologic Malignancies and COVID-19: Perspective of a Large Hematology Center in Greece
por: Spyridis, Nikolaos, et al.
Publicado: (2021)

FRAÇÃO PLAQUETÁRIA IMATURA (IPF) COMO PARÂMETRO DE COAGULAÇÃO EM PACIENTES COM COVID-19: UM ESTUDO PROSPECTIVO
por: Cruz, L.A., et al.
Publicado: (2020)

Assessment of Hematologic and Coagulation Parameters As Predictive Value in COVID-19 with Unfavourable Evolution
por: Popov, Viola Maria, et al.
Publicado: (2020)

Outcomes in Patients with Hematologic Disease and COVID-19 in Russia: Interim Analysis of CHRONOS19 Registry
por: Gavrilina, Olga A., et al.
Publicado: (2020)

Final Results of CHRONOS19 Observational Study in Patients with Hematologic Disease and COVID-19 in Russia
por: Gavrilina, Olga A., et al.
Publicado: (2021)

Four-Fold Increased Mortality from Sars-Cov-2 Infection in Patients with Hematologic Versus Non-Hematologic Malignancies Treated at the Largest Tertiary COVID-19 Center in Chicago/Rush University Medical Center (March 1, 2020-December 31,2020)
por: Yun, Nicole K., et al.
Publicado: (2021)

Use of Monoclonal Antibody Therapy in Hematologic Patients with Mild-to-Moderate COVID-19: A Retrospective Single-Center Experience
por: Amanam, Idoroenyi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_k70ovklsih0bf154nk3ki74420